Radiopharm Theranostics Limited American Depositary Shares (RADX) — Defensive Interval Ratio
Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Defensive Interval Ratio of 271 days as of December 2025. Defensive assets of $11.35 Million (cash $-, short-term investments $-, receivables $11.35 Million) cover 271 days of daily cash needs of $41.86K/day. See how liquid is Radiopharm Theranostics Limited American's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Radiopharm Theranostics Limited American Depositary Shares Defensive Interval Ratio (2022–2025)
This chart shows how Radiopharm Theranostics Limited American Depositary Shares's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 271 days, meaning defensive assets of $11.35 Million can fund 271 days of operations without new revenue. See RADX net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Radiopharm Theranostics Limited American Depositary Shares (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Radiopharm Theranostics Limited American Depositary Shares from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Radiopharm Theranostics Limited American (RADX) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 254 days | $10.40 Million | $40.91K/day | $- | $- | ▲ +234 days |
| 2024 | 21 days | $987.41K | $48.15K/day | $- | $- | ▼ -103 days |
| 2023 | 123 days | $4.47 Million | $36.24K/day | $- | $- | ▲ +121 days |
| 2022 | 3 days | $56.48K | $21.59K/day | $- | $- | — |